1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: agricultural
Astec Lifesciences Limited

Astec Lifesciences Limited

669.20
INR
+3.30
(+0.50%)
-34.77EPS
15.85BMarket Cap
Oct 26Next Earn
Astec Lifesciences Limited
NSE:ASTEC
(National Stock Exchange of India)

Recent

price

669.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
64.26
66.15
100.8
112.22
141.79
118.84
149.86
183.66
218.78
265.12
281.3
342.74
318.01
231.66
192.82
208.17
211.85
Revenue per Share
2.87
0.8
3.43
4.7
7.85
2.53
9.73
17.74
18.14
24.1
32.98
45.52
12.94
-23.75
-68.71
-37.79
-34.79
Basic EPS, GAAP
-11.33
-22.37
-5.51
-2.42
-6.71
-19.67
-0.84
7.61
-19.03
62.47
-56.12
-40.72
-21.57
-63.41
-15.41
-40.28
- -
Free Cash Flow per Basic Share
1.16
0.58
0.57
0.85
1.15
1.49
- -
1.79
1.79
1.49
1.49
1.49
1.49
1.49
- -
- -
- -
Dividend per Share
56.74
57.76
58.16
60.78
58.91
60.21
70.2
86.22
102.77
125.05
156.65
200.78
212.28
186.89
118.79
175.3
- -
Book Value per Share
56.74
57.63
58.08
59.91
57.27
58.52
68.41
84.76
101.55
123.24
154.03
195.01
204.22
177.07
106.92
164.19
- -
Tangible Book Value per Share
17
17
17
18
19
20
20
20
20
20
20
20
20
20
20
21
22
Basic Weighted Avg Shares
1,096
1,128
1,748
2,070
2,669
2,330
2,944
3,613
4,309
5,226
5,549
6,766
6,282
4,577
3,781
4,457
4,580
Sales/Revenue/Turnover
9.11
6.08
9.9
9.98
16.02
10.26
17.33
15.62
15.9
14.25
16.17
17.79
6.93
-9.09
-28.9
-11.08
-9.62
Operating Margin (%)
58
86
119
148
127
104
137
147
193
232
257
344
337
363
437
449
456
Depreciation Expense
49
14
60
87
148
50
191
349
357
475
650
899
256
-469
-1,348
-809
-752
Net Income, GAAP
29.86
29.69
32.22
22.41
- -
59.22
33.28
37.11
36.02
22.53
26.95
25.79
26.76
- -
- -
- -
- -
Effective Tax Rate (%)
4.47
1.21
3.41
4.19
5.54
2.13
6.49
9.66
8.29
9.09
11.72
13.28
4.07
-10.25
-35.63
-18.15
-16.42
Profit Margin (%)
232
118
163
177
47
-118
47
-67
-3
134
82
251
-273
13
-246
-568
- -
Working Capital
24
118
215
181
127
82
4
2
- -
- -
400
- -
109
1,990
2,800
500
- -
LT Debt
970
987
1,059
1,135
1,155
1,181
1,382
1,699
2,028
2,469
3,093
3,967
4,196
3,695
2,350
3,909
- -
Total Equity
3.65
0.82
3.35
4.76
- -
-3.21
10.55
13.63
12.57
14.59
15.62
15.49
4.4
- -
- -
- -
- -
Return on Invested Capital (%)
3.65
0.95
5.94
8.17
- -
4.58
10.87
14.83
12.97
15.81
16.27
16.42
5.61
- -
- -
- -
- -
Return on Capital (%)
5.17
1.4
5.83
7.91
12.91
4.25
14.93
22.69
19.21
21.16
23.41
25.47
6.27
-11.9
-44.62
-25.88
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
3,989
- -
LT Borrowings
- -
500
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
22
22
22
Market Capitalization
15,709
12,046
15,849

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
4,430
- -
Cash, Cash Equivalents & STI
- -
105
- -
Accounts Receivable, Net
- -
2,477
- -
Inventories
- -
1,380
- -
Total Current Liabilities
- -
4,998
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
3,989
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.83%
10.4%
66.34%
Free Cash Flow
-183.92%
45.84%
185.38%
Net Income, GAAP
27%
-33.96%
-39.95%
Sales/Revenue/Turnover
8.39%
-2.37%
17.87%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
694
985
939
1,195
3,781
2026
911
- -
1,247
1,586
4,457
2027
836
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-20.11
-19.66
-20.59
-8.2
-68.71
2026
-16.85
- -
-7.04
-3.48
-37.79
2027
-8.4
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
UPL Limited (NSE:UPL)
Mosaic Company (The) (NYSE:MOS)
CF Industries Holdings, Inc. (NYSE:CF)
PhosAgro (MOEX:PHOR)
Abou Kir Fertilizers & Chemical Industries Co. (EGX:ABUK)
Misr Fertilizers Production Company MOPCO (EGX:MFPC)
Business
Astec LifeSciences Limited Astec LifeSciences Limited manufactures agrochemical active ingredients including triazole fungicides such as Flutriafol, Prothiaconazole, Metalaxyl, and Cyproconazole; herbicides like Azimsulfuron, Halosulfuron, and Rimsulfuron; insecticides such as Transfluthrin; and growth regulators including Tribenuron methyl, alongside pharmaceutical intermediates, bulk formulations, specialty chemicals, and contract development and manufacturing organization services for global agrochemical innovators. The company, founded in 1994 and headquartered in Mumbai, India, operates approximately nine manufacturing plants in Maharashtra, with a sales mix split between domestic Indian markets and exports to over 17 countries across North America, Europe, West Asia, South-East Asia, Latin America, Africa, and Australia. A subsidiary of Godrej Agrovet Limited, it serves the agricultural chemicals industry through a single Agrochemicals segment, focusing on technical actives, intermediates, and custom manufacturing for crop protection and pharmaceutical applications. Recent developments include the inauguration of an advanced R&D center in Rabale, Maharashtra, in 2023 with a US$1.4 million investment to enhance innovation and CDMO capabilities; board approval in October 2025 for re-appointments of independent directors Nandkumar Dhekne and Anjali Gupte, along with related party transactions exceeding materiality thresholds with holding company Godrej Agrovet Limited for FY2025-26; a rights issue announced in June 2025 to raise up to INR2.50 billion, with details finalized for 28,01,673 shares amounting to Rs 249.35 crores as of November 2025; and a strategic shift toward global CDMO partnerships highlighted at Chemspec Europe 2025, including substantial investments in R&D and manufacturing over the past two years.